National Seroprevalence and Trends in Herpes Simplex Virus Type 1 in the United States, 1976–1994

Authors:
  • FXFujie Xu
    Fujie Xu
  • MSMaya Raquel Sternberg
    Maya Raquel Sternberg
  • GAGregory Lee Armstrong
    Gregory Lee Armstrong
  • FLFrancis Kwokshun Lee
    Francis Kwokshun Lee
  • ANAndre Joseph Nahmias
    Andre Joseph Nahmias
  • GMGeraldine Marie McQuillan
    Geraldine Marie McQuillan
  • MLMichael Ernest Louis
    Michael Ernest Louis
  • LMLauri Ellen Markowitz
    Lauri Ellen Markowitz

Abstract
The objectives of this study were to estimate national seroprevalence of herpes simplex virus type 1 (HSV-1), describe trends in seroprevalence, and examine correlates of infection. The goal of this study was to measure the burden of HSV-1 infection in the U.S. population. We tested serum samples for HSV-1 antibody and analyzed questionnaire data collected for the second and third National Health and Nutrition Surveys (NHANES II, 1976–80; NHANES III, 1988—94). Seroprevalence estimates were weighted to represent the total U.S. population. At the time of NHANES III, two thirds (68%) of the U.S. population 12 years and older had HSV-1 antibody. Prevalence increased with age and varied by race/ethnicity; the majority of persons in all race/ethnic groups were HSV-1-seropositive by age 30. Overall, the national seroprevalence of HSV-1 decreased nonsignificantly by 2% in the years between NHANES II and III; decreases in HSV-1 seroprevalence in some population subgroups were balanced by increases in other groups. There was no overall change in the seroprevalence of HSV-1 in the U.S. population between NHANES II and III.

This publication has 47 references indexed in Scilit: